Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT00939523
Title Targeted Therapy With Lapatinib in Patients With Recurrent Pituitary Tumors Resistant to Standard Therapy
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors Cedars-Sinai Medical Center
Indications
Therapies
Age Groups: adult
Covered Countries USA


No variant requirements are available.